Increased Lipoprotein (a) concentrations in patients with chronic venous leg ulcers: a study on patients with or

Markus Zutt1, Ulrich Krüger, Albert Rosenberger

  • 1Department of Dermatology, Venereology and Allergology, University of Göttingen, Göttingen, Germany. mzutt@gwdg.de

Insights

Elevated Lipoprotein (a) [Lp(a)] levels are common in patients with chronic venous leg ulcers, suggesting it may be a novel pathogenic factor. This finding could improve understanding and treatment of these ulcers.

Area of Science:

  • Vascular Medicine
  • Thrombosis Research
  • Dermatology

Background:

  • Chronic venous leg ulcers represent a significant global health burden with complex, not fully understood pathophysiology.
  • Current knowledge gaps exist regarding reliable pathogenic and prognostic markers for these ulcers.
  • Existing data suggest a link between venous leg ulcers and thrombophilia.

Purpose of the Study:

  • To investigate serum Lipoprotein (a) [Lp(a)] levels in patients with chronic venous leg ulcers.
  • To determine if Lp(a) serves as a pathogenic or prognostic parameter in this patient population.
  • To compare Lp(a) levels between patients with and without postthrombotic syndrome and healthy controls.

Main Methods:

  • Serum Lp(a) levels were measured in 210 patients with chronic venous leg ulcers (stratified by postthrombotic syndrome) and 341 healthy controls.
  • Statistical analysis was performed to compare Lp(a) concentrations across the groups.
  • Correlation between Lp(a) and C-reactive protein (CRP) levels was assessed.

Main Results:

  • Significantly higher Lp(a) serum concentrations (>0.3 g/L) were observed in 42% of patients with venous leg ulcers compared to 20% of healthy controls.
  • Increased Lp(a) levels were found in 49% of patients without postthrombotic syndrome versus 35% with the syndrome.
  • Significant differences in Lp(a) levels were noted among all three groups (p<0.001), with no correlation to CRP values.

Conclusions:

  • Serum Lp(a) level is a potential novel pathogenic parameter for chronic venous leg ulcers.
  • Elevated Lp(a) may contribute to ulcer pathogenesis via thrombogenic microcirculatory dysregulation or impaired fibrinolysis.
  • Further research is warranted to elucidate the precise mechanisms of Lp(a) in venous leg ulcer development.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...